Economic evaluation of a shortened standardised treatment regimen of antituberculosis drugs for patients with multidrug-resistant tuberculosis (STREAM): study protocol

INTRODUCTION: Multidrug-resistant tuberculosis (MDR-TB) poses a serious financial challenge to health systems and patients. The current treatment for patients with MDR-TB takes up to 24 months to complete. Evidence for a shorter regimen which differs from the standard WHO recommended MDR-TB regimen...

Descripción completa

Detalles Bibliográficos
Autores principales: Gama, Elvis, Madan, Jason, Langley, Ivor, Girma, Mamo, Evans, Denise, Rosen, Sydney, Squire, S Bertel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Health Economics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5073558/
https://www.ncbi.nlm.nih.gov/pubmed/27798041
http://dx.doi.org/10.1136/bmjopen-2016-014386

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5073558/
https://www.ncbi.nlm.nih.gov/pubmed/27798041
http://dx.doi.org/10.1136/bmjopen-2016-014386

Ejemplares similares